The availability of effective, reliably accessible, and affordable treatments for snakebite
envenoming is a critical and long unmet medical need. Recently, small, synthetic toxin …

A global strategy, under the coordination of the World Health Organization, is being unfolded
to reduce the impact of snakebite envenoming. One of the pillars of this strategy is to ensure …

Snakebite is a medical emergency causing high mortality and morbidity in rural tropical
communities that typically experience delayed access to unaffordable therapeutics. Viperid …

Introduction: Snakebite is an urgent, unmet global medical need causing significant
morbidity and mortality worldwide. Varespladib is a potent inhibitor of venom secretory …

Snake envenomation is still a serious threat to many countries in the world. The only
mainstay treatment depends on the administration of animal derived immunoglobulin based …

Snakebite envenoming is a major cause of morbidity and mortality in rural communities
throughout the tropics. Generally, the main clinical features of snakebites are local swelling …

Snakebite envenoming is a neglected tropical disease that each year claims the lives of
80,000–140,000 victims worldwide. The only effective treatment against envenoming …

The active components of snake venoms encompass a complex and variable mixture of
proteins that produce a diverse, but largely stereotypical, range of pharmacologic effects and …

Snakebite envenoming is responsible for as many as 138 000 deaths annually, making it the
world's most lethal neglected tropical disease (NTD). There is an urgent need to improve …

Morbidity from snakebite envenoming affects approximately 400,000 people annually.
Tissue damage at the bite-site often leaves victims with catastrophic life-long injuries and is …